GMAB · NASDAQ
Genmab A (GMAB) Stock Price & Fundamentals
$496.99−1.23%−$6.17End-of-day price as of Oct 9, 2026
Sample prices
Prices on this page are generated sample data for development, not real market data, so market cap, P/E and dividend yield are illustrative too.
Genmab A (GMAB) closed at $496.99 on Oct 9, 2026, down 1.23% from the previous close of $503.16.
Share price, past year
1Y −23.73%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $496.99 |
| Sep 30, 2026 | $522.49 |
| Aug 31, 2026 | $520.12 |
| Jul 31, 2026 | $512.27 |
| Jun 30, 2026 | $537.00 |
| May 29, 2026 | $565.98 |
| Apr 30, 2026 | $594.65 |
| Mar 31, 2026 | $624.86 |
| Feb 27, 2026 | $621.93 |
| Jan 30, 2026 | $647.55 |
| Dec 31, 2025 | $610.52 |
| Nov 28, 2025 | $627.12 |
| Oct 31, 2025 | $664.16 |
Key statistics
- 52-week range
- $494.52 – $673.95
Financials
Genmab A reports to the SEC in international accounting standards (IFRS), which Laurel doesn't show yet.
Company profile
- Name
- Genmab A/S
- Ticker
- GMAB
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- Toldbodgade 33, 1253 Copenhagen K, G7 00000
- SEC CIK
- 0001434265
Frequently asked questions
What is Genmab A's stock price?
Genmab A (GMAB) closed at $496.99 on Oct 9, 2026, down 1.23% from the previous close of $503.16.
Sources and methodology
Fundamentals come from Genmab A/S's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures